DAG SYRRIST

Dag Syrrist is a distinguished Partner at Viking Global Investors, a globally recognized investment firm known for its fundamental research-driven approach. As a pivotal member of Viking Global's investment team, Syrrist primarily focuses on the dynamic and rapidly evolving healthcare and life sciences sectors. His expertise spans a broad range of areas within these industries, including biotechnology, pharmaceuticals, medical devices, and healthcare services. He is instrumental in identifying companies with strong growth potential and sustainable competitive advantages, contributing significantly to Viking Global's long/short equity strategies.

Syrrist's career at Viking Global Investors began in 2001, marking over two decades of dedicated service and significant contributions to the firm's success. Before joining Viking Global, he honed his strategic and analytical skills as a consultant at McKinsey & Company, a global management consulting firm. This foundational experience provided him with a robust understanding of business operations, market dynamics, and strategic planning, which he has effectively applied to the investment landscape.

Academically, Dag Syrrist is well-credentialed, holding an MBA from Harvard Business School, one of the world's most prestigious business programs. His academic background also includes an M.Sc. from the Norwegian Institute of Technology, further solidifying his analytical capabilities and technical understanding. This combination of top-tier business education and a strong technical foundation underpins his rigorous investment analysis and decision-making process.

At Viking Global, Syrrist is known for his deep dive into company fundamentals, market trends, and scientific advancements within healthcare. He seeks out innovative companies poised for disruption or significant growth, often engaging in thorough due diligence to assess management teams, product pipelines, and intellectual property. While specific notable investments are often proprietary to the hedge fund's strategies, his long tenure and senior role suggest a consistent track record of identifying valuable opportunities that align with Viking Global's investment philosophy. His work is crucial in navigating the complexities of the healthcare market, which requires a nuanced understanding of regulatory environments, scientific breakthroughs, and patient needs. Dag Syrrist continues to be a driving force in Viking Global Investors' pursuit of superior risk-adjusted returns within the critical healthcare and life sciences domains.